In an endeavor to develop new and evaluate the existing diagnostic
tools, imaging or therapeutics in clinical or population settings, the
Department of Biotechnology (DBT), Government of India, has invited the
research proposals for early and accurate diagnosis of active, latent
and MDR tuberculosis. DBT expects industry, academia, and
non-governmental organizations, individually or in consortium to
participate in its efforts to develop the accurate diagnostic
technology.
The proposals must directly aim at providing them at the primary care
clinic level preferably under a program like Revised National TB
Control Program (RNTCP). The grants will support critically needed
equipments, consumables, personnel and contingency expenses. The
duration of the proposal may be of two to three years.
The expected performance characteristics of point-of-care (POC)
diagnostics have been fixed and these include the requirements such as
higher specificity and sensitivity than the existing tests, readable
results within four to six hours, specimen processing rate of 20
tests/day. The specimen options should have varied-sputum, blood,
urine, saliva, CSF and tissues, and the technology should be
self-contained, portable, battery-operated with option for charging and
requisite minimum maintenance. The shelf-life is expected to be at
least 24 months at temperature below 35°C and in varied humidity
conditions and be cost-effective at the same time. Also, the duration
of training has been fixed as two to three days for a field-based
health worker.
In addition to that, DBT has also invited proposals for two diagnostic
tools that are already in use in other parts of the world to be made
indigenously under ‘Import Substitution Package’. One is real-time PCR
for rapid diagnosis of tuberculosis and MDR-TB using technologies like
molecular, real-time nucleic acid amplification (NAA). The other is
Line Probe Assay (LPA) for rapid diagnosis of MDR-TB using technologies
like polymerase chain reaction and reverse line probe hybridization
with mutation-specific labeled probes.
Under this category, DBT is looking for industrial partners and
academia to take up the technology challenges in making self-contained
kit/device or one/multiple component/s of the two devices with
willingness to license/commercialize the product, making it available
in Indian/outside markets as an affordable one. The last date for
sending the proposals has been kept as August 31, 2010.
Nanotech R&D grows in personal
care industry
Small particles are becoming a big business for the world’s personal
care products manufacturers according to an analysis of world patent
activity published by the IP solutions business of Thomson Reuters. The
new report, ‘Can Nanotech Unlock the Fountain of Youth?’, finds that
the beauty industry has begun to make an aggressive foray into
nanotechnology, using tiny molecular compounds to improve the
performance of creams, sunscreens, shampoos and other personal-care
products.
The report tracks unique inventions published in patent applications
and granted patents from 2003 to 2009, along with trademark data from
2000 through to 2009, to identify the companies and areas of
nanotechnology innovation showing the sharpest growth in this industry.
The global study shows expansion in nanotech-based personal care
products and brands with Japan, China and Korea as key growth markets.
The study finds that the growth of nanotech is getting accelerated. The
volume of innovative patents involving nanotech in beauty and
personal-care items grew by 103 percent over the last seven years, more
than doubling from 181 patents in 2003 to 367 in 2009.